Global Immunotherapy Market is Projected to Observe a High growth rate of CAGR 13-14% by 2027 - Changing Cancer Outcomes & Standard of Care for Advanced Malignancies
Growing cancer cases, the arrival of innovative treatment techniques such as chimeric antigen receptor (CAR) T-cell therapy, cancer vaccines, adoptive cell transfer (ACT) therapy are some of the major factors driving the immunotherapy market. However, the high cost of immunotherapy and the availability of less expensive treatments such as chemotherapy are projected to stifle the growth of the immunotherapy industry. Cancer Immunotherapy is a treatment that use the body's immune system to combat cancer cells. It stimulates the immune system, causing it to recognize and combat cancer cells. The treatment either uses compounds produced by the body or substances created in a laboratory to identify and combat cancer cells. Immunotherapy can be used alone or in combination with chemotherapy or other cancer treatments to treat various forms of cancer. Cancer Immunotherapy Market: Leading Market Trends Cancer immunotherapy is rapidly progressing and is already licensed for the treatment...